The Evidence series analysers brings the power of Biochip Array Technology (BAT) Multiplex testing to your laboratory. BAT is a multi-analyte platform which provides an unrivaled increase in results per sample. This Evidence series analysers includes the Evidence RABTA, Evidence Investigator and Evidence MultiSTAT. Developed to meet the needs of each user, the Evidence Series is designed to provide financial, labour and time savings for the end user. Utilising this technology, the Evidence series guarantees cost-effective, highly accurate and flexible testing solutions.
Analysers
Evidence Rabta
A next‑generation random‑access biochip analyser designed for continuous workflow, high efficiency, and rapid results. Delivers precise, reliable diagnostics across a wide assay range with seamless, uninterrupted operation.
Evidence MultiSTAT
An automated, on‑site analyser delivering simultaneous detection of up to 29 drugs, classical, prescription, and synthetic, from a single sample. Powered by Biochip Array Technology, it provides a full immunoassay profile within minutes across multiple sample types.
Evidence Investigator
A compact semi‑automated analyser using Biochip Array Technology to detect multiple drug metabolites from one sample. Offers a broad toxicology menu, making it a cost‑effective, efficient drug‑screening solution.
What is Biochip?
Biochip Array Technology is an immunoassay testing platform allowing for the simultaneous multi-analyte screening of a panel of related tests. The technology works by combining a panel of up to 48 tests on a single Biochip with a single set of reagents, controls and calibrators. Our Biochip Array Technology forms part of our unrivalled toxicology test menu detecting over 600 drugs and drug metabolites.
